Joshua R. Disbrow
Chief Executive Officer at Aytu BioPharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Aytu BioPharma Inc., 3 years.
Aytu BioPharma Inc.
Director · Chief Executive Officer
Chief executive roles
Aytu BioPharma Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 28, 2026 | Aytu BioPharma Inc. | Grant or award | +30,000 | — | — |
| Oct 3, 2025 | Aytu BioPharma Inc. | Grant or award | +31,446 | — | — |
| Oct 3, 2025 | Aytu BioPharma Inc. | Grant or award | +22,500 | — | — |
| Jun 9, 2025 | Aytu BioPharma Inc. | Open-market purchase | +66,666 | $1.50 | $99,999 |
| Feb 28, 2025 | Aytu BioPharma Inc. | Open-market purchase | +15,000 | $1.30 | $19,500 |
| Jun 14, 2023 | Aytu BioPharma Inc. | Open-market purchase | +14,000 | $1.86 | $26,040 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.